BUSINESSCipla InvaGen Facility Gets VAI Status From USFDATabassum ChaudharyAugust 31, 2026August 31, 2026 August 31, 2026August 31, 2026 Cipla has disclosed that the USFDA classified its InvaGen New York plant inspection as Voluntary Action Indicated, closing the regulatory review. The plant is Unit...
Latest NewsCipla has completed acquisition of US cos InvaGen and ExelanadminFebruary 18, 2016 February 18, 2016 On Thursday, Cipla the pharma major has completed the acquisition of InvaGen and Exelan. This acquisition has come as a major positive for Cipla to...